Perspective Therapeutics ... (CATX)
AMEX: CATX
· Real-Time Price · USD
3.58
-0.32 (-8.21%)
At close: Aug 15, 2025, 3:59 PM
3.67
2.66%
After-hours: Aug 15, 2025, 05:01 PM EDT
Perspective Therapeutics Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 342K | 342K | n/a | 337K | 2.25M | 3.75M | 5.58M | 7.07M | 6.88M | 7.89M | 8.97M | 9.95M | 10.79M | 11M | 10.69M | 10.23M | 10.05M | 9.62M |
Cost of Revenue | 732K | 732K | n/a | n/a | 1.45M | 3.29M | 4.86M | 6.29M | 6.15M | 5.89M | 5.78M | 5.95M | 6.18M | 5.96M | 5.73M | 5.33M | 4.93M | 4.78M |
Gross Profit | -390K | -390K | n/a | 337K | 799K | 459K | 713K | 779K | 731K | 2M | 3.18M | 4M | 4.62M | 5.04M | 4.96M | 4.9M | 5.12M | 4.85M |
Operating Income | -83.41M | -99.71M | -90.89M | -53.71M | -45.61M | -42.72M | -40.92M | -36.32M | -29.99M | -20.72M | -10.72M | -9.16M | -7.22M | -6.21M | -5.77M | -5.01M | -3.45M | -3.54M |
Interest Income | 10.77M | 11.69M | 10.52M | 7.93M | 4.55M | 1.77M | 934K | 1.27M | 1.21M | 942K | 597K | 228K | 119K | 123K | 115K | 89K | 59K | 28K |
Pretax Income | -97.05M | -86.84M | -80.49M | -47.09M | -42.05M | -41.88M | -40.93M | -34.96M | -28.95M | -19.92M | -10.39M | -9.1M | -7.27M | -6.25M | -5.65M | -4.92M | -3.39M | -3.51M |
Net Income | -94.95M | -85.17M | -79.28M | -63.78M | -59.02M | -58.42M | -46.51M | -24.03M | -17.6M | -8.51M | -9.35M | -8.75M | -7.07M | -6.12M | -5.65M | -4.92M | -3.39M | -3.51M |
Selling & General & Admin | 30.77M | 28.58M | 26.61M | 20.06M | 18.64M | 19.11M | 21.06M | 22.36M | 20.73M | 16.98M | 11.41M | 10.74M | 9.43M | 9.16M | 8.66M | 8.08M | 7.13M | 7.1M |
Research & Development | 55.86M | 48.52M | 41.64M | 34.84M | 28.53M | 24.91M | 21.31M | 15.84M | 10.83M | 5.97M | 2.67M | 2.59M | 2.58M | 2.25M | 2.07M | 1.82M | 1.43M | 1.28M |
Other Expenses | 23.51M | 23.51M | 23.53M | -5.53M | -5.53M | -5.53M | -5.44M | -231K | -231K | -233K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 111.23M | 101.17M | 92.34M | 48.47M | 40.83M | 37.6M | 36.06M | 37.09M | 30.72M | 22.72M | 14.08M | 13.33M | 12.01M | 11.41M | 10.72M | 9.9M | 8.56M | 8.38M |
Interest Expense | 5K | 147K | 48K | 145K | 90K | 93K | 82K | 458K | 584K | 558K | 540K | 140K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | -2.58M | -1.72M | -812K | n/a | 3.39M | 3.34M | 3.08M | 2.96M | 2.84M | 2.8M | 2.81M | 2.7M | 2.62M | 2.44M | 2.47M |
Cost & Expenses | 85.68M | 99.95M | 91.12M | 48.47M | 42.28M | 40.89M | 40.92M | 43.39M | 36.87M | 28.61M | 19.86M | 19.27M | 18.19M | 17.38M | 16.46M | 15.23M | 13.49M | 13.15M |
Income Tax Expense | -2.1M | -2.16M | -2.16M | 7.79M | 8.07M | 7.91M | -2.59M | -11.14M | -11.56M | -11.41M | -1.05M | -373K | -262K | -771K | -662K | -845K | -951K | -471K |
Shares Outstanding (Basic) | 74.23M | 72.36M | 70.63M | 70.63M | 66.65M | 49.51M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M |
Shares Outstanding (Diluted) | 74.23M | 72.36M | 70.63M | 70.63M | 66.65M | 49.51M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M | 54.91M |
EPS (Basic) | -1.32 | -1.21 | -1.21 | -1.09 | -1.07 | -1.09 | -0.85 | -0.44 | -0.32 | -0.16 | -0.17 | -0.16 | -0.13 | -0.11 | -0.1 | -0.08 | -0.05 | -0.05 |
EPS (Diluted) | -1.32 | -1.21 | -1.21 | -1.09 | -1.07 | -1.09 | -0.85 | -0.44 | -0.32 | -0.16 | -0.17 | -0.16 | -0.13 | -0.11 | -0.1 | -0.08 | -0.05 | -0.05 |
EBITDA | -73.62M | -86.34M | -80.46M | -45.09M | -40.51M | -40.91M | -40.12M | -34.64M | -29.04M | -20.07M | -10.79M | -9.32M | -7.33M | -6.32M | -5.71M | -4.93M | -3.43M | -3.52M |
EBIT | -75.44M | -86.69M | -80.44M | -46.95M | -31.89M | -32.01M | -31.43M | -25.78M | -25.78M | -14.41M | -4.41M | -1.21M | -3.48M | -3.48M | -2.27M | -2.27M | n/a | n/a |
Depreciation & Amortization | 2.12M | 2.69M | 2.31M | 1.85M | 1.44M | 1.11M | 1.32M | 1.16M | 965K | 785K | 62K | 24K | 15K | -8K | 197K | 174K | 149K | 141K |